Does Red Light Therapy Really Work for Lip Lines? What the Clinical Data Shows

Why Lip Lines Are One of the Hardest Signs of Aging to Treat

The perioral area — the skin surrounding the lips — is among the most structurally complex and treatment-resistant zones on the face. Lip lines, commonly called “barcode lines,” develop from a combination of factors that standard skincare products are poorly equipped to address.

The skin in this region is thinner than elsewhere on the face, with a higher density of sebaceous glands and a constant mechanical load from speaking, eating, and facial expression. Collagen and elastin degradation in this zone accelerates with age, UV exposure, and repetitive movement — producing the fine vertical lines that radiate above and below the lip border.

Topical retinoids and peptides can provide modest surface-level improvement, but they do not address the underlying structural deficit. Injectables remain the clinical standard for lip line correction — but they carry cost, recovery time, and the risk of unnatural results. Red light therapy via photobiomodulation offers a third category: a non-invasive, clinically substantiated mechanism that works at the cellular level to stimulate the biological processes responsible for collagen synthesis, tissue repair, and skin firmness.

The Photobiomodulation Mechanism in the Perioral Zone

Photobiomodulation (PBM) is the process by which specific wavelengths of red and near-infrared light stimulate mitochondrial activity within skin cells. The primary chromophore is cytochrome c oxidase — an enzyme in the mitochondrial electron transport chain. When activated by red light wavelengths, cytochrome c oxidase increases ATP production, which in turn drives cellular processes including:

•      Collagen synthesis — fibroblast stimulation to produce new Type I and Type III collagen in the dermis

•      Elastin restoration — improvement in dermal elasticity and mechanical resilience

•      Reduced inflammatory signaling — downregulation of cytokines that accelerate tissue degradation

•      Enhanced microcirculation — improved delivery of oxygen and nutrients to perioral tissue

What makes LushLips Transformation clinically distinct is that it is designed specifically for the perioral anatomy — delivering targeted photobiomodulation to the precise zone where lip lines form, with hands-free, bite-free wearability that enables consistent treatment durations proven in the clinical protocol.

The Clinical Study: 84 Days, Independent Laboratory, Biometric Instrumentation

The LushLips Transformation clinical program was developed in partnership with a former senior regulatory executive at Avon and Johnson & Johnson, and Adjunct Professor of Cosmetic Science at Rutgers University.

Study Parameters

•      30 volunteers, ages 30–65, all skin types

•      84-day duration — exceeding the typical 28-day cosmetic study standard

•      Evaluation timepoints: Day 0, Day 28, Day 56, Day 84

•      Dermatologist supervision throughout

•      Instrumental biometric analysis, dermatologist grading, and consumer self-assessment

Instrumentation

•      AEVA3D-HE2 — 3D imaging for wrinkle density, surface roughness, and volumetric lip analysis

•      Cutometer® — biomechanical measurement of skin firmness and elasticity

•      Corneometer® — stratum corneum hydration quantification

•      MoistureMap — topographic hydration mapping

•      Glossymeter — skin radiance and light reflection quantification

The Results: What the Biometric Data Showed

Wrinkle Reduction

•      42–46% reduction in perioral wrinkle density — statistically significant

•      Up to -44% median wrinkle density reduction confirmed by AEVA3D 3D imaging

•      83% of participants showed visible improvement in perioral wrinkles — confirmed by independent dermatologist evaluation

•      Measurable reduction in wrinkle depth and surface roughness via 3D surface mapping

Firmness & Elasticity

•      17–23% statistically significant gains in firmness and elasticity via Cutometer® biomechanical testing

•      Improved biomechanical resilience of perioral tissue

•      84% of consumers reported feeling tighter, firmer skin

Lip Volume & Contour

•      Measurable increase in lower lip volume via AEVA3D volumetric imaging

•      87% showed enhanced lip contour and definition — confirmed by dermatologist grading

•      85% of consumers reported lips looked plumper and smoother

Hydration & Radiance

•      Consistent upward hydration trends via MoistureMap and Corneometer®

•      Significant increase in light reflection and skin luminosity by Days 56 and 84 via Glossymeter

•      78% of consumers reported brighter, more radiant skin

Safety & Tolerability

•      94% reported no adverse effects

•      No serious adverse events reported across all 84 days of dermatologist-monitored testing

•      97% reported comfortable treatments

Independent Recognition: Awards, Editorial, and Television

The clinical data has been independently validated by some of the most credible voices in beauty and dermatology.

Harper’s Bazaar

LushLips Transformation was named one of the 6 Best Red Light Therapy Devices for Lips by Harper’s Bazaar. In a category crowded with devices making unsubstantiated claims, LushLips earned its place on that list on the strength of its clinical science and targeted perioral design.

CosmoProf Overall Award — Skin and Body Care Products, 2024

CosmoProf is the professional beauty industry’s most authoritative trade platform. The Overall Award in the Skin and Body Care Products division represents peer recognition from the professional beauty community — not a consumer popularity contest.

Shape Award for Skin, 2025

Shape Magazine’s annual beauty awards are among the most widely read consumer beauty recognitions in the United States. The 2025 Shape Award for Skin places LushLips among the most trusted skincare innovations of the year.

Good Morning America with Dr. Dendy Engelman

LushLips Transformation was featured on Good Morning America alongside board-certified dermatologist Dr. Dendy Engelman — one of the most respected voices in clinical dermatology and aesthetic medicine in the United States.

FDA 510(k) Clearance: What It Means and Why It Matters

LushLips Transformation is FDA 510(k)-cleared for perioral wrinkle reduction. This is not a cosmetic claim or a marketing designation.

FDA 510(k) clearance means the device has been reviewed and determined by the U.S. Food and Drug Administration to be substantially equivalent to a legally marketed predicate device in terms of intended use and technological characteristics. It requires submission of safety and efficacy data, device specifications, and clinical evidence. The vast majority of LED beauty devices on the market today do not hold FDA clearance for wrinkle reduction — they operate under general wellness or cosmetic classifications. LushLips is cleared as a medical device for a specific therapeutic indication. That distinction is clinically and legally significant.

Who Is LushLips Transformation For?

LushLips Transformation is designed for anyone seeking a clinically substantiated, non-invasive approach to perioral aging. It is particularly well suited for:

•      Adults 30+ beginning to notice the development of lip line and perioral wrinkling

•      Individuals seeking an evidence-based alternative or complement to injectable treatments

•      Those who have tried topical treatments without achieving meaningful results in the perioral zone

•      Anyone looking for a clinical-grade device validated by an independent 84-day study, not a 28-day cosmetic trial

Experience the Clinical Difference

LushLips Transformation is available now at metamorphosislighttherapy.com. FDA 510(k)-cleared, independently clinically studied for 84 days, and recognized by Harper’s Bazaar, Shape, CosmoProf, and Good Morning America.

Metamorphosis doesn’t follow beauty trends. It follows the science.

About the Author

Sally Gardocki, Esquire is the CEO and Founder of Metamorphosis Light Therapy, LLC — a Charleston, SC-based clinical beauty technology company built on photobiomodulation science. Metamorphosis devices are substantiated by independent 84-day biometric clinical studies. The company holds multiple FDA 510(k) clearances and nine provisional utility patents filed in 2026.